961PFirst results of safety profile of nivolumab (NIVO) in...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

961PFirst results of safety profile of nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in II and III line of patients (pts) with metastatic renal cell carcinoma (mRCC) in NIVES study

Masini, C, Ciammella, P, Timon, G, Gnoni, R, De Giorgi, U F F, Bellia, S R, Buti, S, Salaroli, F, Milella, M, Mazzarotto, R, Mucciarini, C, Vitale, M G, Bruni, A, Procopio, G, Kinspergher, S, Nole, F,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.057
Date:
October, 2019
File:
PDF, 78 KB
2019
Conversion to is in progress
Conversion to is failed